Ritter Pharmaceuticals

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

You can watch RTTR and buy or sell other stocks, options, and ETFs commission-free!

About RTTR

Ritter Pharmaceuticals, Inc. engages in the development of novel therapeutic products which modulate the human gut microbiome to treat digestive disorders and gastrointestinal diseases. It focuses on the development and commercialization of RP-G28. 

CEO
Andrew J. Ritter, MBA
CEOAndrew J. Ritter, MBA
Employees
46
Employees46
Headquarters
Los Angeles, California
HeadquartersLos Angeles, California
Founded
2004
Founded2004
Employees
46
Employees46

RTTR Key Statistics

Market cap
434.51M
Market cap434.51M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
227.18K
Average volume227.18K
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$3.12
52 Week high$3.12
52 Week low
$0.2595
52 Week low$0.2595
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.